Promoting healthy weight during and after pregnancy
Official title: Promoting Healthy Weight Across the Pregnancy and Postpartum Period Through Dissemination of an Evidence Based Intervention
Run by Washington University School of Medicine · NCT04253977 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests a program to help overweight or obese women manage their weight during and after pregnancy to promote healthier lifestyles.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 784 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (Saint Louis, Missouri) |
| Trial ID | NCT04253977 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 18-45 who are pregnant, overweight or obese, and willing to participate in the Parents as Teachers program.
✕Probably not a fit
Patients who are planning to become pregnant again before their baby turns one or those unable to engage in a walking program may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project evaluates the effectiveness of the HEALTH-P2 intervention aimed at preventing excessive weight gain during pregnancy and up to 12 months postpartum. The intervention will be implemented through the Parents as Teachers (PAT) program, which trains parent educators to deliver the program in real-world settings. The study will assess weight outcomes among overweight or obese women and evaluate the implementation of the intervention across PAT's national network. By addressing the challenges of weight management during the childbearing years, this study seeks to promote healthier lifestyles and reduce obesity-related health risks.
Why it matters
Potential benefit: If successful, this intervention could help women manage their weight effectively during and after pregnancy, reducing the risk of obesity and related chronic diseases.
How similar studies have gone: Other studies have shown success with similar lifestyle interventions aimed at managing weight during pregnancy, indicating potential for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
For Parent educators: Inclusion Criteria: * Deliver PAT at a site participating in the study * Provide informed consent Exclusion Criteria: • At least 18 years of age For the participants: Inclusion Criteria: * 18-45 years of age * pregnant * overweight or obese (BMI over 25 kg/m2) before becoming pregnant * English or Spanish speaking * participating or willing to participate in PAT at a participating PAT site until baby turns 1 * able to give informed consent for participation Exclusion Criteria: * planning to become pregnant again before their baby turns 1 * unable to engage in a walking program
Where it's running
-
Washington University in St. Louis
Saint Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Debra Haire-Joshu, PhD — Washington University School of Medicine
- Study coordinator: Rachel Tabak, PhD, RD
- Email: rtabak@wustl.edu
- Phone: 314-935-0153
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ocular Changes in People Using Tirzepatide or Semaglutide
This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Berobenatide for knee pain in adults who are overweight or with obesity
This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists
This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.